Ingredients

TPI Enterprises buys Vistin opiates assets and confirms Portugal plant plan

iStock/aniszewski

TPI Enterprises has bought Vistin Pharma ASA’s opiates and tabletting division for A$25.4m ($201.m) in a deal designed to expand the firm beyond its narcotic raw materials business.

iStock/Bet_Noire

WHO prequalifies Mylan's India unit to supply TB drug API

iStock/MaxxieMW

Rousselot is first gelatin firm to join IPEC Europe

iStock/Rost-9D

Nitto Denko Avecia’s expanded API site to open in Massachusetts, US

iStock/robmen

Gilead HIV drug API sourcing suit reopened by US Appeal Court

iStock/ronniechua

Canada's Medicure exercises option to buy US-Indian API firm Apicore

iStock/vchal

Newlink expands indoximod IP with US prodrug patent

iStock/XtockImages

PMDA confirms investigation of Osaka API firm Yamamoto Chemical

An illegal meth lab. Image: iStock/wellphoto

Bayer ends methamphetamine abuse deterrent partnership with Acura

iStock/Makidotvn

Immediate-release formulation means fewer pills and more flexibility, says Roche

More Ingredients